U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07644013) titled 'Prospective Multicenter Registry Study of Multiple System Atrophy in China' on June 08.
Brief Summary: Multiple system atrophy is a rare, rapidly progressive neurodegenerative disease characterized by variable combinations of parkinsonism, cerebellar ataxia, and autonomic dysfunction. Existing natural history studies from North America, Europe, and Japan suggest that clinical phenotypes and disease progression may differ across populations. However, comprehensive multicenter prospective data from Chinese patients with multiple system atrophy remain limited.
This prospective multicenter registry study aims to describe the clinical c...